These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 22354875)

  • 1. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yes is a central mediator of cell growth in malignant mesothelioma cells.
    Sato A; Sekine M; Virgona N; Ota M; Yano T
    Oncol Rep; 2012 Nov; 28(5):1889-93. PubMed ID: 22948717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
    Indovina P; Giorgi F; Rizzo V; Khadang B; Schenone S; Di Marzo D; Forte IM; Tomei V; Mattioli E; D'Urso V; Grilli B; Botta M; Giordano A; Pentimalli F
    Oncogene; 2012 Feb; 31(7):929-38. PubMed ID: 21785466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors.
    Tamm C; Galitó SP; Annerén C
    Exp Cell Res; 2012 Feb; 318(4):336-49. PubMed ID: 22197704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events.
    Werdich XQ; Penn JS
    Angiogenesis; 2005; 8(4):315-26. PubMed ID: 16400523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.
    Sato I; Obata Y; Kasahara K; Nakayama Y; Fukumoto Y; Yamasaki T; Yokoyama KK; Saito T; Yamaguchi N
    J Cell Sci; 2009 Apr; 122(Pt 7):965-75. PubMed ID: 19258394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Src family kinases overcomes anoikis resistance induced by spheroid formation and facilitates cisplatin-induced apoptosis in human mesothelioma cells.
    Eguchi R; Fujita Y; Tabata C; Ogawa H; Wakabayashi I; Nakano T; Fujimori Y
    Oncol Rep; 2015 Nov; 34(5):2305-10. PubMed ID: 26323315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells.
    Kashiwagi K; Virgona N; Harada K; Kido W; Yano Y; Ando A; Hagiwara K; Yano T
    Life Sci; 2009 May; 84(19-20):650-6. PubMed ID: 19232361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation.
    Luciano F; Ricci JE; Auberger P
    Oncogene; 2001 Aug; 20(36):4935-41. PubMed ID: 11526478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
    Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
    Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways.
    Cui QL; Fogle E; Almazan G
    Neurochem Int; 2006 Apr; 48(5):383-93. PubMed ID: 16439036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion.
    Usami N; Sekido Y; Maeda O; Yamamoto K; Minna JD; Hasegawa Y; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
    Oncogene; 2003 Sep; 22(39):7923-30. PubMed ID: 12970740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
    Congleton J; MacDonald R; Yen A
    Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells.
    Kuga T; Nakayama Y; Hoshino M; Higashiyama Y; Obata Y; Matsuda D; Kasahara K; Fukumoto Y; Yamaguchi N
    Arch Biochem Biophys; 2007 Oct; 466(1):116-24. PubMed ID: 17692281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
    Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
    Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines.
    Golubovskaya VM; Gross S; Kaur AS; Wilson RI; Xu LH; Yang XH; Cance WG
    Mol Cancer Res; 2003 Aug; 1(10):755-64. PubMed ID: 12939401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.
    Masachika E; Kanno T; Nakano T; Gotoh A; Nishizaki T
    Anticancer Res; 2013 Mar; 33(3):887-94. PubMed ID: 23482758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
    Fallacara AL; Passannanti R; Mori M; Iovenitti G; Musumeci F; Greco C; Crespan E; Kissova M; Maga G; Tarantelli C; Spriano F; Gaudio E; Bertoni F; Botta M; Schenone S
    Eur J Med Chem; 2019 Nov; 181():111545. PubMed ID: 31400706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.